Abstract

Fragile X-associated tremor ataxia syndrome is an untreatable neurological and neuromuscular disorder caused by unstable expansion of 55–200 CGG nucleotide repeats in 5′ UTR of Fragile X intellectual disability 1 (FMR1) gene. The expansion of CGG repeats in the FMR1 mRNA elicits neuronal cell toxicity through two main pathogenic mechanisms. First, mRNA with CGG expanded repeats sequester specific RNA regulatory proteins resulting in splicing alterations and formation of ribonuclear inclusions. Second, repeat-associated non-canonical translation (RANT) of the CGG expansion produces a toxic homopolymeric protein, FMRpolyG. Very few small molecules are known to modulate these pathogenic events, limiting the therapeutic possibilities for FXTAS. Here, we found that a naturally available biologically active small molecule, Curcumin, selectively binds to CGG RNA repeats. Interestingly, Curcumin improves FXTAS associated alternative splicing defects and decreases the production and accumulation of FMRpolyG protein inclusion. Furthermore, Curcumin decreases cell cytotoxicity promptly by expression of CGG RNA in FXTAS cell models. In conclusion, our data suggest that small molecules like Curcumin and its derivatives may be explored as a potential therapeutic strategy against the debilitating repeats associated neurodegenerative disorders.

Highlights

  • Many, if not all, cellular functions are controlled by changes in mRNA or non-coding RNA expression and regulations (Sharp, 2009)

  • Previous studies have reported that the stabilization of CGG repeat RNA via small molecule ameliorates Fragile X-associated tremor ataxia syndrome (FXTAS) associated pathogenic defects (Yang et al, 2016b)

  • Biophysical characterization using circular dichroism (CD) spectroscopy, CD melting and gel retardation illustrate the specific binding of Curcumin with CGG repeats RNA

Read more

Summary

Introduction

If not all, cellular functions are controlled by changes in mRNA or non-coding RNA expression and regulations (Sharp, 2009). Regions causes various disorders, like, Fragile X-associated tremor ataxia syndrome (FXTAS), Fragile X-associated primary ovarian insufficiency (FXPOI) (Fraint et al, 2014; Groh et al, 2014), Huntington’s disease (HD) (Urbanek et al, 2017), Spinocerebellar ataxia type 10 (SCA10) (Bushara et al, 2013) Amyotrophic lateral sclerosis (ALS) (Balendra and Isaacs, 2018), Huntington’s disease-like 2 (HDL2) and Myotonic dystrophy type 1 (DM1) (López-Morató et al, 2018) These repeats expansion (CGG, CAG, GGGGCC, AUUCU, CCUG, CUG, etc.) elicit neuronal toxicity via overlapping pathogenic mechanisms such as toxic protein and RNA gain-of-function, and protein loss-of-function (Orr and Zoghbi, 2007; Nageshwaran and Festenstein, 2015; Freibaum and Taylor, 2017). CGG repeats longer than 200 trigger CpG methylation that results in epigenetic silencing of the FMR1 gene and subsequently decrease expression of the FMR protein, leading to a different pathology, the neurodevelopmental Fragile X syndrome characterized by autism and intellectual disability

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call